Stay updated on Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.

Latest updates to the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedAn updated revision tag appears in the history: v3.6.3 replaces v3.6.0, signaling a newer version of the study record on this page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNew quick-access actions were added to the history page: 'Check who can join' and 'Find Contact Information', improving navigation to eligibility and contact details. The page now displays Revision: v3.6.0 and removes the previous Revision: v3.5.5 entry.SummaryDifference0.3%

- Check33 days agoChange DetectedA new revision entry, v3.5.5, has been added to the history and the prior v3.5.4 entry has been removed. This reflects an updated release noted in the page's revision history.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision (v3.5.4) was added to the page, replacing the previous revision (v3.5.3) in the history. This updates the revision metadata for the study record history.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor ClinicalTrials.gov site/version update rather than a change to the recorded trial information.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history.SummaryDifference0.1%

Stay in the know with updates to Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.